Cardiovascular Risk Reduction with Icosapent Ethyl for HypertriglyceridemiaDeepak L. Bhatt, Christie M. Ballantyne, Lixia Jiao et al.|New England Journal of Medicine|2018Cited by 3.2k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary SyndromeMarc A. Pfeffer, Jean‐Claude Tardif, Brian Claggett et al.|New England Journal of Medicine|2015Cited by 2.3k
Effect of Very High-Intensity Statin Therapy on Regression of Coronary AtherosclerosisSteven E. Nissen, for the ASTEROID Investigators, Stephen J. Nicholls et al.|JAMA|2006Cited by 2k
Effects of Dalcetrapib in Patients with a Recent Acute Coronary SyndromeGregory G. Schwartz, R. Scott Wright, Anders Olsson et al.|New England Journal of Medicine|2012Cited by 2k
Inflammation in heart failure: pathophysiology and therapeutic strategiesJacinthe Boulet, Michel White, Vikas S. Sridhar et al.|Inflammation Research|2024Cited by 129